Elisabetta Munzone and Oncology - Free people check

(1 - 17 from 18

)

CDK4/6 inhibitors plus endocrine therapy benefit subset of breast ...www.healio.com › news › hematology-oncology › cdk46-inhibitors-plus-e...

www.healio.com

Jun 18, · ... therapy deeply transformed the treatment landscape of HR-positive HER2-negative advanced breast cancer,” Elisabetta Munzone, MD, ...

History of Changes for Study: NCT

clinicaltrials.gov

Study Officials: Elisabetta Munzone, MD Principal Investigator IEO. Locations: Italy. European Institute of Oncology Milan, Italy ...

Lancet Oncology, The - Vol n° 4 - EM consulte

www.em-consulte.com

... Eduardo Diaz-Rubio, Jonathan Krell, Sarah-Jane Dawson, Cristina Raimondi, Annemie Rutten, Wolfgang Janni, Elisabetta Munzone, Vicente Carañana, Sofia Agelaki, Camillo Almici, Luc Dirix, Erich-Franz Solomayer, Laura Zorzino, Helene Johannes, Jorge S Reis-Filho, Klaus Pantel, Jean-Yves Pierga, Stefan Michiels.

Hematology/Oncology Clinics of North America - Vol n° 4 - EM...

www.em-consulte.com

Le site de référence en informations médicales et paramédicales - EM|consulte

Breast Cancer, An Issue of Hematology/Oncology Clinics of North...

books.google.de

This issue, focusing on Breast Cancer, includes topics such as: Radiation Therapy for DCIS, Axillary dissection, Pathology in the age of personalized breast...

Breast Cancer, An Issue of Hematology/Oncology Clinics of North ...books.google.com › books

books.google.de

Tailoring Adjuvant Treatments for the IndividualPatient with LuminalBreast Cancer Elisabetta Munzone,MDa∗,GiuseppeCurigliano,MD,PhDb andMarcoColleoni, MDa, ...

Dr Elisabetta Munzone - ecancerecancer.org › journal › editorial-board › 20-dr-elisabetta-munzone

ecancer.org

Elisabetta Munzone, MD, is Deputy Director at the IEO, Division of Medical Oncology. She is a clinician and researcher with major interest in breast cancer, ...

Elisabetta Munzone - EasyChaireasychair.org › smart-program › VPH2018 › person80

easychair.org

Elisabetta Munzone. Organization: European Institute of Oncology. Pages in this Program. Program · Program for Wednesday, September 5th ...

CONFERENCE PROCEEDINGS | In Silico Onc Med

www.in-silico-oncology.iccs.ntua.gr

Katerina Argyri, Elisabetta Munzone, Laura Adamoli, Georgios Stamatakos: In Silico Oncology: A vascular tumour growth based Oncosimulator for reproducing ...

Clinical overview of metronomic chemotherapy in breast cancer

go.gale.com

Author(s): Elisabetta Munzone and Marco Colleoni . Source: Nature Reviews Clinical Oncology. Document Type: Report. Abstract : Over 15 years ago, low-dose ...

Does Immediate Breast Reconstruction after Mastectomy and ...ar.iiarjournals.org › content › figures-only

ar.iiarjournals.org

... GIUSEPPE CURIGLIANO,; NICOLE ROTMENSZ,; ELISABETTA MUNZONE and; ARON GOLDHIRSCH. + Author Affiliations. 1European Institute of Oncology, ...

Prognostic Value of Circulating Tumor Cells According to...

www.infona.pl

Elisabetta Munzone. Division of Medical Oncology, Istituto Europeo di Oncologia, Milan, Italy. Edoardo Botteri. Division of Epidemiology and ...

CAELYX® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer...

clinicaltrials.gov

Contact: Elisabetta Munzone, MD + ext Principal Investigator: Elisabetta Munzone, MD, European Institute of Oncology ...

Lancet Oncology, The - Présentation - EM consultewww.em-consulte.com › clinical-validity-of-circulating-tumour-cells-in-p

www.em-consulte.com

... MD, Wolfgang Janni, ProfMD, Elisabetta Munzone, MD, Vicente Carañana, MD, Sofia Agelaki, MD, Camillo Almici, MD, Luc Dirix, MD, Erich-Franz Solomayer, ...

Nicole Rotmensz
Marco Colleoni
Sofia Agelaki

Giuseppe Curigliano
Urszula Ledzewicz
Robert Kerbel

People
Forename "Elisabetta" (3319)
Name "Munzone" (13)

sorted by relevance / date

Advanced Search

Search name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Elisabetta Munzone and Oncology Free People Check

CDK4/6 inhibitors plus endocrine therapy benefit subset of breast ...www.healio.com › news › hematology-oncology › cdk46-inhibitors-plus-e...

History of Changes for Study: NCT

Lancet Oncology, The - Vol n° 4 - EM consulte

Hematology/Oncology Clinics of North America - Vol n° 4 - EM...

Breast Cancer, An Issue of Hematology/Oncology Clinics of North...

Breast Cancer, An Issue of Hematology/Oncology Clinics of North ...books.google.com › books

Dr Elisabetta Munzone - ecancerecancer.org › journal › editorial-board › 20-dr-elisabetta-munzone

Elisabetta Munzone - EasyChaireasychair.org › smart-program › VPH2018 › person80

CONFERENCE PROCEEDINGS | In Silico Onc Med

Clinical overview of metronomic chemotherapy in breast cancer

Does Immediate Breast Reconstruction after Mastectomy and ...ar.iiarjournals.org › content › figures-only

Prognostic Value of Circulating Tumor Cells According to...

CAELYX® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer...

Lancet Oncology, The - Présentation - EM consultewww.em-consulte.com › clinical-validity-of-circulating-tumour-cells-in-p

Palbociclib for HR Positive / HER2-negative Isolated Locoregional ...clinicaltrials.gov › show › NCT

Prognostic value of Ki-67 labeling index in patients with...

Tailoring adjuvant treatments for the individual patient with luminal...

All web results to the name "Elisabetta Munzone"